Pharmaceutical Business review

Bioenergy appoints new CEO

Dr Khankari joins the company from Cima Labs, a Cephalon company, where he served as general manager and vice president for worldwide drug delivery technologies.

Dr Khankari earned his initial degrees in pharmaceutics from universities in India. Dr Khankari also has a PhD in pharmaceutics and an MBA from the University of Minnesota.

Bud Hayden, interim CEO of Bioenergy, said: “We are very pleased to have Dr Khankari head up our company. His scientific background, including his successful track record in working with the FDA on new product discoveries, in conjunction with the experience he gained in holding senior management positions, will provide the leadership Bioenergy needs to take advantage of our strong intellectual property portfolio.”